Skip to main content

Gloria Melanie

In the past year, 7 open-market sale filings worth $1.60M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$1.60M
7 filings
Net
−$1.60M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Gloria Melanie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

IMVT Immunovant, Inc.

Chief Operating Officer7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 21, 2025 (view filing)Nov 201 dayGloria MelanieChief Operating OfficerSSale−12.6K$23.62−$298.2K−6.8%173.5K after2 lots
Feb 27, 2026 (view filing)Feb 252 daysGloria MelanieChief Operating OfficerSSale−3.24K$27.85−$90.2K−1.9%170.3K after3 lots
Apr 10, 2026 (view filing)Apr 82 daysGloria MelanieChief Operating OfficerSSale−8.72K$24.83−$216.6K−3.4%245.2K after
May 22, 2026 (view filing)May 202 daysGloria MelanieChief Operating OfficerSSale−3.12K$32.45−$101.1K−1.3%242.1K after3 lots
Jun 26, 2026 (view filing)Jun 26Same dayGloria MelanieChief Operating OfficerSSale−17.7K$38.31−$678.6K−7.3%224.4K after2 lots
Jul 10, 2026 (view filing)4:15 PM ETJul 82 daysGloria MelanieChief Operating OfficerSSale−2.04K$39.55−$80.5K−0.9%222.4K after2 lots
Aug 21, 2026 (view filing)4:03 PM ETAug 201 dayGloria MelanieChief Operating OfficerSSale−3.06K$44.16−$135.0K−1.4%219.3K after